🇺🇸 FDA
Patent

US 8618096

Prodrug compositions and methods for using the same in treating cancer and malaria

granted A61PA61P3/00A61P33/06

Quick answer

US patent 8618096 (Prodrug compositions and methods for using the same in treating cancer and malaria) held by The Regents of the University of California expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P3/00, A61P33/06